Female Urogenital Diseases Clinical Trial
Official title:
Center of Assisted Reproductive Technology
The purpose of this study is to determine whether laser-assisted zona thinning improve the implantation rate of the women of advanced age in the first IVF/ICSI cycles
Registry procedures:
1. It's required to sign an informed consent form prior to the recruitment of all
patients.
2. Data collection and entry need double check and supervision.
The outcome measures:
the implantation rate per embryo transfer miscarriage live birth
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02244151 -
Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval
|
Phase 2 | |
Completed |
NCT04735549 -
Vulvovaginal Atrophy Correction Using Neodymium Laser
|
N/A | |
Recruiting |
NCT05000957 -
Pelvic Organs Prolapse Treatment Using Neodymium Laser
|
N/A | |
Completed |
NCT03562897 -
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
|
Phase 2 | |
Completed |
NCT02774031 -
Comparison of Gas Consumption From Two Different Anesthesia Machines
|
N/A | |
Not yet recruiting |
NCT05585476 -
A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.
|
N/A | |
Withdrawn |
NCT03996057 -
Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention
|
Phase 4 | |
Recruiting |
NCT06237920 -
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
|
Phase 2 | |
Recruiting |
NCT06114940 -
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC
|
Phase 2 | |
Completed |
NCT05463081 -
Clinical Trial of "Magic Gyno" Laser Device
|
N/A | |
Completed |
NCT03996603 -
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
|
Phase 4 |